Salute e Benessere

The Frost & Sullivan Institute Honors Global Organizations Pioneering…

The award selection framework follows a rigorous eight-step evaluation process conducted in collaboration with Frost & Sullivan's global think tank. Companies are then reviewed for leadership best practices, benchmarked on innovation and sustainability metrics, and vetted through multiple independent perspectives. The award selection framework follows a rigorous eight-step evaluation process conducted in collaboration with Frost & Sullivan's global think tank. Companies are then…
PR Newswire
01/12/2025

Cosmo and Glenmark Announce Market Authorisation of Winlevi® (clascoterone) 10…

Giovanni Di Napoli, Chief Executive Officer of Cosmo, commented, "This approval reflects the strength of our collaboration with Glenmark and our shared commitment to advancing dermatologic care. Winlevi represents a first-in-class topical innovation that redefines how acne is treated, and we are excited to see it become accessible to patients throughout Europe." Giovanni Di Napoli, Chief Executive Officer of Cosmo, commented,"This approval reflects the strength of our…
PR Newswire
01/12/2025

Akura Medical, a Shifamed Portfolio Company, Closes $53 Million in Series C…

"Akura Medical is advancing a differentiated portfolio of venous thrombectomy technologies aimed at improving procedural precision and patient outcomes. The recent introduction of our NavIQ quantification software represents the next step toward intelligent, data-driven thrombectomy," said Amr Salahieh, Chair and Acting Chief Executive Officer, Akura Medical. "This new capital enables us to accelerate product development and continue building the foundation for long-term growth…
PR Newswire
01/12/2025

SmartSkin Launches Pharma Seal Assurance Solution to Deliver Real-Time Insights…

SmartSkin Seal Assurance provides per-head, real-time feedback on sealing performance by measuring and visualizing forces during capping. Each event generates a digital signature, creating auditable proof that every capper head is configured and operating within specification. This record helps confirm setup quality and consistency. Compatible with single and multi-head systems, it complements Residual Seal Force (RSF) testing by confirming that sealing conditions measured in RSF are...
PR Newswire
01/12/2025

Philips expands commercial availability of world’s first real-time AI-enabled…

Commercial availability expanded across Europe and the United StatesReal-time AI-enabled 3D device visualization powered by light instead of X-ray, improving navigation in complex endovascular proceduresLumiGuide seamlessly integrates with Azurion, Philips’ proven, world-leading image-guided therapy platform designed to drive procedural innovation across clinical domains Amsterdam, the Netherlands and Chicago, USA –Royal Philips(NYSE: PHG, AEX: PHIA,a global leader in...
Nasdaq GlobeNewswire
01/12/2025

MediView Achieves First CE Mark, Bringing Augmented Reality to European…

The line between the physical and digital world has been blurred, equipping clinicians with the information they need at the point of care to make the best decisions for patients. This transformative imaging technology is being leveraged as an alternative to traditional, cumbersome 2D imaging solutions by giving physicians the ability to improve workflow efficiency, ergonomics, and 3D visualization, while unlocking new levels of spatial awareness and real-time data access. MediView's system uses…
PR Newswire
01/12/2025

ProMIS Neurosciences Announces New Peer-Reviewed Publication Showing Plasma pTau…

Cross-trial analysis supports plasma pTau as a potential early predictor of clinical benefit, reinforcing the biomarker-driven design of ProMIS’ PRECISE-AD trialProMIS on track to leverage new plasma pTau insights with planned Q2 2026 interim readout Cambridge, Massachusetts, Dec.01, 2025(GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of antibody therapeutics and vaccines targeting toxic...
Nasdaq GlobeNewswire
01/12/2025

Dyadic and BRIG BIO Sign Development & Commercialization Agreement to Bring…

This partnership combines Dyadic’s innovation capabilities with BRIG BIO’s expertise in dairy and medical nutrition, with the goal of advancing scalable, cost-effective production of animal-free alpha-lactalbumin for early life, active, healthy aging, and medical nutrition markets. Together, the companies aim to accelerate commercialization timelines, support commercially viable production, enhance market affordability, and expand global access to sustainable proteins with comparable...
Nasdaq GlobeNewswire
01/12/2025

ProMIS Neurosciences to Participate in the 8th Annual Evercore Healthcare…

thAnnual Evercore Healthcare Conference on Tuesday, December 2nd, 2025.The fireside chat will be held at 3:25pm Eastern Time and a live webcast of the presentation may be accessed by visiting the Events page of the Company’s website at www.promisneurosciences.com . The webcast will be available for at least 30 days following the event. About ProMIS Neurosciences Inc. ProMIS Neurosciences is a clinical-stage biotechnology company committed to the discovery and development of...
Nasdaq GlobeNewswire
01/12/2025

Juniper Biosciences Raises Oversubscribed and Upsized $40 Million Seed Financing…

Financing co-led by NovaCapital, private high-net-worth individuals and members of Club Degli Investitori “We are thrilled to have the support of a diverse investor base who believe strongly in the promise that radiopharmaceuticals offer to the future of patient care.” said Alex Agnoletto, CEO. “Our founding team brings deep expertise within global radiopharmaceutical development and manufacturing and is well positioned to advance our pipeline to address patient needs.” About Juniper...
Nasdaq GlobeNewswire
01/12/2025

Zentiva Expands into Biologics with the EU-Wide Launch of Its First Biosimilar

"Today's launch is a key moment for Zentiva," said Steffen Saltofte, CEO, Zentiva. "We are taking a significant step into the field of biological medicines. Biosimilars are a natural extension of our mission to make high-quality treatments more accessible and affordable for people across Europe. This expansion also positions Zentiva for sustainable growth in one of the most dynamic segments of the pharmaceutical industry." "Today's launch is a key moment for…
PR Newswire
01/12/2025

AbbVie to Present Phase 3 ECLIPSE Data Demonstrating Atogepant (AQUIPTA®)…

The Phase 3 ECLIPSE study demonstrated that atogepant was superior to placebo in achieving pain freedom at two hours after treatment of the first migraine attack in adults with a history of migraine (with or without aura) (24.3% for atogepant vs. 13.1% for placebo; odds ratio 2.36, 95% CI [1.76, 3.15]; p<0.0001). Additionally, the first 12 of the 16 key secondary endpoints met statistical significance, including freedom from MBS at 2 hours after treatment (p<0.0001).1 The Phase 3 ECLIPSE…
PR Newswire
01/12/2025

Clue Unveils Our Year In Cycles: A Candid Look at How We Bled, Felt, Loved and…

Exclusive cycle tracking data reveals 280 million days of bleeding were tracked across the globe in the last 12 monthsApp users logged 34 million sex sessions and 4.4 million orgasms across 202544.6 million days of cramps were recorded, the equivalent of 122,000 years of pain if shouldered by one person Our Year in Cyclesis an annual snapshot of hormones and health, with the aim of tackling taboo and stigma around the menstruation conversationLONDON, Dec.01, 2025(GLOBE...
Nasdaq GlobeNewswire
01/12/2025

Introducing Kamvas Pro 27 (144Hz): The Industry's First 27-inch 4K Pen Display…

For example, when working on frame-by-frame animation, animators need to repeatedly preview sequences. The 144Hz screen delivers incredibly smooth and clear visuals, making it easier to spot any unnatural motion, stuttering, or jitter, and enabling precise adjustments. For example, when working on frame-by-frame animation, animators need to repeatedly preview sequences. The 144Hz screen delivers incredibly smooth and clear visuals, making it easier to spot any unnatural motion, stuttering, or...
PR Newswire
01/12/2025

Hedia appoints new CEO: Rasmus Kofoed to succeed Lars Christian Lund

Carl Bilbo, Chairman of the Board of Hedia, commented: Carl Bilbo, Chairman of the Board of Hedia, commented: "Under Lars Christian Lund's leadership, Hedia has progressed from an ambitious start‑up to a professional scale‑up with strong regulatory and commercial development. Lars has played a central role in strengthening the organisation, securing MDR approval and building the foundation for global growth. On behalf of the board I wish to thank him for his outstanding contribution and...
PR Newswire
01/12/2025

Medit recognized as the top brand in a global brand perception study by an…

According to the report, Medit achieved the highest overall brand perception score among the major intraoral scanner brands included in the analysis. Within this dataset, sentiment toward Medit was characterized by 29.9% explicitly positive feedback—the highest share of positive sentiment among the brands analyzed—highlighting strong recognition of Medit's IOS performance, software experience, and overall value in user-generated comments related to IOS usage and impressions. According to the...
PR Newswire
01/12/2025

Oxurion verzekert een bindende financieringsfaciliteit van EUR 30 miljoen voor…

Leuven, BELGIË – 1 december 2025 – 8u00 CET Oxurion NV (Euronext Brussel: OXUR), een farmaceutische onderaannemingsvennootschap gevestigd in Leuven, kondigt de ondertekening aan van een inschrijvingsovereenkomst met Atlas Capital Markets betreffende een financiering via converteerbare obligaties, voor een totaalbedrag van €30 miljoen, verdeeld over 12 tranches van telkens €2,5 miljoen…
Actusnews Wire
01/12/2025

Breda University develops VR tool to resist alcohol temptation during festive…

For many people recovering from alcohol addiction, the festive season in December presents a difficult challenge. The social context brings with it increased anxiety and risk of relapse. This can lead to isolation: parties and family gatherings are avoided, which in turn can lead to alcohol consumption. Research shows that 47-75% of patients fall back within a year of clinical treatment. For many people recovering from alcohol addiction, the festive season in December presents a difficult…
PR Newswire
01/12/2025

Oxurion secures a binding EUR 30 million financing facility dedicated to…

Leuven, BELGIUM – December 1 , 2025 – 08:00 AM CET - Oxurion NV (Euronext Brussels: OXUR), a pharmaceutical outsourcing company based in Leuven, announces the signing of a subscription agreement with Atlas Capital Markets for a financing via convertible bonds, for a total amount of €30 million, divided into 12 tranches of €2.5 million each…
Actusnews Wire
01/12/2025

Addex Therapeutics to Report 2025 Third Quarter Financial Results And Host…

Geneva, Switzerland, December 1, 2025-Addex Therapeutics(SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today announced that it will report its Third Quarter 2025 Financial Results on December 4, 2025. Tim Dyer, CEO and Mikhail Kalinichev, Head of Translational Science, will provide a business update and review of the Addex product pipeline during a...
Nasdaq GlobeNewswire
01/12/2025

Ipsen mourns the passing of Henri Beaufour, a founding family Board member

PARIS, FRANCE, 1 DECEMBER 2025- It is with great sadness that Ipsen (Euronext: IPN; ADR: IPSEY) today announces that Henri Beaufour, Ipsen Board Member and a representative of the founding family, passed away on Friday, 28 November 2025.Henri Beaufour, together with his sister Anne Beaufour, played a pivotal role in supporting the company’s strategic direction and upholding the values established by the Beaufour family. The Board of Directors and Executive Leadership Team extend their...
Nasdaq GlobeNewswire
01/12/2025

Perlis Royalty Join Prof. Mike Chan in Strengthening Malaysia's Fight Against…

Rising Needs in Malaysia Rising Needs inMalaysia Perlis, like many parts of the country, has seen an increase in autism prevalence among school-aged children. Through UniMAP and the A-HEART Autism Hub, the Perlis royal household has invested in early identification, teacher training and family support programs. Their visit inKuala Lumpurhighlighted the need to extend such efforts nationally. Prof.Mike Chan'sGlobal Autism Mission Prof. Chan's work on autism began more...
PR Newswire
30/11/2025

The Bioregenerative Sports Revolution: How Prof. Mike Chan Is Changing Athlete…

Because what started in Sabah is now heading to the biggest sporting stage in the world: the Super Bowl. Because what started inSabahis now heading to the biggest sporting stage in the world: the Super Bowl. And behind it all is a man who's been preparing for this moment for over 40 years —Prof. Dato' Sri Dr.Mike Chan . How It All Started inSabah In late 2025, Sabah FC signed a deal withEuropean Wellness Premier Center (EWPC)in Kota Kinabalu,Sabah. Their goal? To...
PR Newswire
30/11/2025

Philips launches Verida, world’s first detector-based spectral CT powered by…

Philips pioneered detector-based spectral CT, which has been widely adopted in clinical routine exams across anatomies, supported by over 800 peer-reviewed publications [1]CE-marked, 510k pending Verida CT [2] integrates AI across the imaging chain, providing superb image quality while accelerating workflow and reducing dose [3, 4] Amsterdam, the Netherlands and Chicago, USA– At RSNA 2025,Royal Philips(NYSE: PHG, AEX: PHIA), a global leader in health technology, today...
Nasdaq GlobeNewswire
30/11/2025
Altri  Comunicati